<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107648</article-id><article-id pub-id-type="doi">10.7554/eLife.107648</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Cancer</subject></subj-group></article-categories><title-group><article-title>Reading the DNA of telomeres</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Roy</surname><given-names>Shamayita</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0001-9732-1446</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Shamayita Roy</bold> is in the Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal</p></bio></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Azzalin</surname><given-names>Claus M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9396-1980</contrib-id><email>claus.azzalin@gimm.pt</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/><bio><p><bold>Claus M Azzalin</bold> is in the Gulbenkian Institute for Molecular Medicine and the Faculty of Medicine, University of Lisbon, Lisbon, Portugal</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0346k0491</institution-id><institution>Gulbenkian Institute for Molecular Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Lisbon</named-content></addr-line><country>Portugal</country></aff></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>18</day><month>06</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e107648</elocation-id><permissions><copyright-statement>© 2025, Roy and Azzalin</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Roy and Azzalin</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107648-v1.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.106657" id="ra1"/><abstract><p>Experiments with tools designed to detect DNA damage reveal unique and conserved features of telomeres in cancer cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>telomeres</kwd><kwd>ssDNA</kwd><kwd>dsDNA</kwd><kwd>END-seq</kwd><kwd>alternative lengthening of telomeres</kwd><kwd>cancer</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Experiments with tools designed to detect DNA damage reveal unique and conserved features of telomeres in cancer cells.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Azeroglu B, Wu W, Pavani R, Sandhu R, Matsumoto T, Nussenzweig A, Lazzerini Denchi E. 2025. Conserved and unique features of terminal telomeric sequences in ALT-positive cancer cells. <italic>eLife</italic> <bold>14</bold>:RP106657. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.106657">10.7554/eLife.106657</ext-link>.</p></boxed-text><p>To proliferate uncontrollably, cancer cells need to maintain the length of their telomeres, regions of DNA that act as protective “caps” at the ends of chromosomes. In most healthy somatic cells, telomeres shorten slightly after every cell division. Once a finite number of divisions has been reached, telomeres become critically short and halt any further proliferation, creating a barrier to cancer development (<xref ref-type="bibr" rid="bib4">Harley et al., 1990</xref>; <xref ref-type="bibr" rid="bib6">Jones-Weinert et al., 2025</xref>).</p><p>Approximately 85% of human cancers overcome this barrier by activating telomerase, an enzyme that extends telomeres but is not normally expressed in somatic cells. The remaining cancers rely on a specialized DNA repair pathway called Alternative Lengthening of Telomeres (or ALT for short), which elongates short telomeres by copying DNA from a longer telomere within the same cell (<xref ref-type="bibr" rid="bib3">Dilley et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">O’Sullivan and Greenberg, 2025</xref>).</p><p>Telomeres consist of two strands of DNA, which each contain a specific sequence of base pairs: TTAGGG and its complementary strand CCCTAA. At the end of the telomere, the strand rich in the base guanine (G) extends past its complementary strand to form a single-stranded region of 50–200 bases, known as the G-overhang (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="bibr" rid="bib6">Jones-Weinert et al., 2025</xref>). While the general structure of telomeres is well characterized, much less is understood about how the telomeres of ALT-positive cancer cells differ from those that rely on telomerase (ALT-negative cells). Now, in eLife, Eros Lazzerini Denchi and colleagues at the National Cancer Institute – including Benura Azeroglu as first author – report repurposing an established DNA sequencing method to investigate key features of telomeres in these different types of cancer cell (<xref ref-type="bibr" rid="bib2">Azeroglu et al., 2025</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Unique and conserved telomere features in cancer cells that use different telomere maintenance mechanisms.</title><p>In cancer cells, the telomeres (red) covering the end of chromosomes (black) are maintained and lengthened by either the ALT pathway (ALT-positive cells; bottom) or the enzyme telomerase (ALT-negative cells; top). ALT-positive cells, ALT-negative cells and non-cancer cells (not shown) share several features: a conserved 5’ terminus ending with the base pair sequence ATC (underlined), and a G-overhang at the 3’ terminus. The telomeres in ALT-positive cells also contain regions of ssDNA that are not found in ALT-negative cells or non-cancer cells. The method employed by Azeroglu et al. did not establish whether the ssDNA within ALT telomeres is C- or G-rich. ALT: alternative lengthening of telomeres; ssDNA: single-stranded DNA; dsDNA: double-stranded DNA.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107648-fig1-v1.tif"/></fig><p>The team employed END-seq, a powerful sequencing method which was originally developed to map double-stranded breaks across the genome (<xref ref-type="bibr" rid="bib10">Wong et al., 2021</xref>). Since the end of chromosomes resemble one end of a double-stranded break, END-seq should identify telomeres as unidirectional reads rather than the bidirectional reads that characterize typical double-stranded breaks. By using this technique on human cell lines that express telomerase, Azeroglu et al. confirmed it could identify ‘telomeric reads’, which were defined based on whether they were unidirectional and contained at least four consecutive TTAGGG (G-rich) or CCCTAA (C-rich) repeats. Almost all of the identified telomeric reads derived from the C-rich strand, as would be expected when looking at telomeres as one-ended double-stranded breaks, confirming the robustness of the approach.</p><p>Applying this technique to a variety of cancerous and non-cancerous cell lines as well as mouse tissues revealed that the ends of chromosomes in ALT-positive cells are remarkably similar to those in ALT-negative and non-cancerous cells. In all cases, the 5′ end of the telomeres typically terminated with an ATC sequence (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Loss of the telomere-binding protein POT1 – which regulates the 5’ end sequence at the end of chromosomes in ALT-negative cells (<xref ref-type="bibr" rid="bib5">Hockemeyer et al., 2005</xref>) – also altered the telomere sequence of cancer cells that rely on the ALT pathway. This is a striking finding given that telomeres elongated by ALT are typically considered to be structurally distinct: they are highly heterogeneous in length, possess long G-overhangs, and are enriched in unusual secondary structures (<xref ref-type="bibr" rid="bib1">Arora et al., 2014</xref>; <xref ref-type="bibr" rid="bib9">O’Sullivan and Greenberg, 2025</xref>; <xref ref-type="bibr" rid="bib11">Yang et al., 2021</xref>). Yet, despite these structural differences, the findings of Azeroglu et al. suggest that key features in the organization of telomeres are conserved across ALT-positive and ALT-negative cells.</p><p>This raised the question of whether ALT-positive telomere DNA sequences have other unique features that distinguish them from those lengthened by telomerase. To explore this, Azeroglu et al. took advantage of S1-END-seq, a newer version of END-seq that can detect internal stretches of single-stranded DNA (ssDNA) within telomeres (<xref ref-type="bibr" rid="bib7">Matos-Rodrigues et al., 2022</xref>). This approach identified frequent internal ssDNA regions within the telomeres of ALT-positive cells. Although this method did not reveal whether the ssDNA regions are C-rich or G-rich, it clearly demonstrated that they are a hallmark of ALT-positive cells, as these regions were virtually absent from telomerase-positive cancer cells and non-cancer cells (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>The study by Azeroglu et al. has several important implications. First, it supports the notion that the telomeres of ALT-positive cells are inherently damaged or incompletely replicated, as the presence of internal ssDNA regions likely reflects defective telomere replication (<xref ref-type="bibr" rid="bib8">Mazzucco et al., 2020</xref>). Second, the S1-END-seq technique offers a robust way to distinguish ALT-positive from ALT-negative cancers. Translating this method to clinical settings could improve how well tumors are classified and aid in stratifying patients for personalized treatments. Third, studying how ssDNA regions are formed and maintained in ALT-positive cells may uncover vulnerabilities that could be exploited therapeutically. For instance, ssDNA is inherently unstable and, if unprotected, can lead to DNA breaks, genome instability and cell death. Future studies should focus on scaling up S1-END-seq to identify the factors that are shielding these fragile ssDNA regions and develop drugs that specifically disrupt their function.</p><p>Taken together, the work of Azeroglu et al. highlights that, sometimes, less is more. While the scientific community continues to push boundaries to develop new tools to dissect the biology of cancer cells, these findings demonstrate that repurposing existing methodologies can yield important insights.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Founder and shareholder of TessellateBIO</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Wischnewski</surname><given-names>H</given-names></name><name><surname>Brun</surname><given-names>CM</given-names></name><name><surname>Schwarz</surname><given-names>T</given-names></name><name><surname>Azzalin</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>5220</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6220</pub-id><pub-id pub-id-type="pmid">25330849</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azeroglu</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Pavani</surname><given-names>R</given-names></name><name><surname>Sandhu</surname><given-names>R</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Nussenzweig</surname><given-names>A</given-names></name><name><surname>Lazzerini Denchi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Conserved and unique features of terminal telomeric sequences in ALT-positive cancer cells</article-title><source>eLife</source><volume>14</volume><elocation-id>RP106657</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.106657</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dilley</surname><given-names>RL</given-names></name><name><surname>Verma</surname><given-names>P</given-names></name><name><surname>Cho</surname><given-names>NW</given-names></name><name><surname>Winters</surname><given-names>HD</given-names></name><name><surname>Wondisford</surname><given-names>AR</given-names></name><name><surname>Greenberg</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Break-induced telomere synthesis underlies alternative telomere maintenance</article-title><source>Nature</source><volume>539</volume><fpage>54</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/nature20099</pub-id><pub-id pub-id-type="pmid">27760120</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harley</surname><given-names>CB</given-names></name><name><surname>Futcher</surname><given-names>AB</given-names></name><name><surname>Greider</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Telomeres shorten during ageing of human fibroblasts</article-title><source>Nature</source><volume>345</volume><fpage>458</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1038/345458a0</pub-id><pub-id pub-id-type="pmid">2342578</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hockemeyer</surname><given-names>D</given-names></name><name><surname>Sfeir</surname><given-names>AJ</given-names></name><name><surname>Shay</surname><given-names>JW</given-names></name><name><surname>Wright</surname><given-names>WE</given-names></name><name><surname>de Lange</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end</article-title><source>The EMBO Journal</source><volume>24</volume><fpage>2667</fpage><lpage>2678</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600733</pub-id><pub-id pub-id-type="pmid">15973431</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones-Weinert</surname><given-names>C</given-names></name><name><surname>Mainz</surname><given-names>L</given-names></name><name><surname>Karlseder</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Telomere function and regulation from mouse models to human ageing and disease</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>26</volume><fpage>297</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1038/s41580-024-00800-5</pub-id><pub-id pub-id-type="pmid">39614014</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matos-Rodrigues</surname><given-names>G</given-names></name><name><surname>van Wietmarschen</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Tripathi</surname><given-names>V</given-names></name><name><surname>Koussa</surname><given-names>NC</given-names></name><name><surname>Pavani</surname><given-names>R</given-names></name><name><surname>Nathan</surname><given-names>WJ</given-names></name><name><surname>Callen</surname><given-names>E</given-names></name><name><surname>Belinky</surname><given-names>F</given-names></name><name><surname>Mohammed</surname><given-names>A</given-names></name><name><surname>Napierala</surname><given-names>M</given-names></name><name><surname>Usdin</surname><given-names>K</given-names></name><name><surname>Ansari</surname><given-names>AZ</given-names></name><name><surname>Mirkin</surname><given-names>SM</given-names></name><name><surname>Nussenzweig</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>S1-END-seq reveals DNA secondary structures in human cells</article-title><source>Molecular Cell</source><volume>82</volume><fpage>3538</fpage><lpage>3552</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2022.08.007</pub-id><pub-id pub-id-type="pmid">36075220</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzucco</surname><given-names>G</given-names></name><name><surname>Huda</surname><given-names>A</given-names></name><name><surname>Galli</surname><given-names>M</given-names></name><name><surname>Piccini</surname><given-names>D</given-names></name><name><surname>Giannattasio</surname><given-names>M</given-names></name><name><surname>Pessina</surname><given-names>F</given-names></name><name><surname>Doksani</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Telomere damage induces internal loops that generate telomeric circles</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5297</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19139-4</pub-id><pub-id pub-id-type="pmid">33082350</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Sullivan</surname><given-names>RJ</given-names></name><name><surname>Greenberg</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Mechanisms of alternative lengthening of telomeres</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>17</volume><elocation-id>a041690</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a041690</pub-id><pub-id pub-id-type="pmid">39500623</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Nussenzweig</surname><given-names>A</given-names></name><name><surname>Canela</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>END-seq: an unbiased, high-resolution, and genome-wide approach to map DNA double-strand breaks and resection in human cells</article-title><source>Methods in Molecular Biology</source><volume>2153</volume><fpage>9</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0644-5_2</pub-id><pub-id pub-id-type="pmid">32840769</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>SY</given-names></name><name><surname>Chang</surname><given-names>EYC</given-names></name><name><surname>Lim</surname><given-names>J</given-names></name><name><surname>Kwan</surname><given-names>HH</given-names></name><name><surname>Monchaud</surname><given-names>D</given-names></name><name><surname>Yip</surname><given-names>S</given-names></name><name><surname>Stirling</surname><given-names>PC</given-names></name><name><surname>Wong</surname><given-names>JMY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>G-quadruplexes mark alternative lengthening of telomeres</article-title><source>NAR Cancer</source><volume>3</volume><elocation-id>zcab031</elocation-id><pub-id pub-id-type="doi">10.1093/narcan/zcab031</pub-id><pub-id pub-id-type="pmid">34316718</pub-id></element-citation></ref></ref-list></back></article>